Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04660760
Title Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Academic and Community Cancer Research United
Indications

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

Therapies

Paclitaxel + Ramucirumab

Ramucirumab + Trifluridine-tipiracil hydrochloride

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.